Characterisation of Burkholderia pseudomallei Lethal Factor 1 (BLF1). A breakthrough against melioidosis;Découverte du premier facteur létal de Burkholderia pseudomallei, BLF1: Une avancée majeure pour contrer la mélioïdose

Medecine/Sciences

Volumn 28, Issue 3, 2012, Pages 262-264

  Hautbergue, Guillaume ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL TOXIN; BACTERIAL VACCINE; BLF1 TOXIN, BURKHOLDERIA PSEUDOMALLEI; EXOTOXIN; HELICASE; INITIATION FACTOR 4A;

AMINO ACID SUBSTITUTION; ANIMAL; ARTICLE; BIOLOGICAL WARFARE; BURKHOLDERIA PSEUDOMALLEI; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; MELIOIDOSIS; METABOLISM; MICROBIOLOGY; MOLECULARLY TARGETED THERAPY; PATHOGENICITY; PHYSIOLOGY; SPECIES DIFFERENCE; VIRULENCE;

AMINO ACID SUBSTITUTION; ANIMALS; ANTINEOPLASTIC AGENTS; BACTERIAL TOXINS; BACTERIAL VACCINES; BIOLOGICAL WARFARE; BURKHOLDERIA PSEUDOMALLEI; CELLS, CULTURED; DNA HELICASES; EUKARYOTIC INITIATION FACTOR-4A; EXOTOXINS; HUMANS; MELIOIDOSIS; MOLECULAR TARGETED THERAPY; SPECIES SPECIFICITY; VIRULENCE;

BURKHOLDERIA PSEUDOMALLEI;

EID: 84860809306     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2012283011     Document Type: Article

References (10)

1. Wiersinga WJ, van der Poll T, White NJ, et al. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 2006;4:272-82.
2. Patel N, Conejero L, De Reynal M, et al. Development of vaccines against burkholderia pseudomallei. Front Microbiol 2011;2:198.
3. Stone R. Infectious disease. Racing to defuse a bacterial time bomb. Science 2007;317:1022-4. (Pubitemid 47330160)
4. Wheelis M. First shots fired in biological warfare. Nature 1998;395:213. (Pubitemid 28447526)
5. Estes DM, Dow SW, Scheizer HP, Torres AG. Present and future therapeutic strategies for melioidosis and glanders. In: Fong IW, Alibek K, eds. Bioterrorism and infectious agents. A new dilemma for the 21st century. New York: Springer, 2005:99-145.
6. Holden MT, Titball RW, Peacock SJ, et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci USA 2004;101:14240-5. (Pubitemid 39305059)
7. Wongtrakoongate P, Mongkoldhumrongkul N, Chaijan S, et al. Comparative proteomic profiles and the potential markers between Burkholderia pseudomallei and Burkholderia thailandensis. Mol Cell Probes 2007;21:81-91. (Pubitemid 46074387)
8. Cruz-Migoni A, Hautbergue GM, Artymiuk PJ, et al. A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A. Science 2011;334:821-4.
9. Malina A, Cencic R, Pelletier J. Targeting translation dependence in cancer. Oncotarget 2011;2:76-88.
10. Batrakova EV, Gendelman HE, Kabanov AV. Cellmediated drug delivery. Expert Opin Drug Deliv 2011;8:415-33.